6509--Warfarin Tablets (VA-25-00012328)
ID: 36E79725R0007Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS, VETERINARY USE (6509)

Original Source

https://sam.gov/opp/59a733f331fa4c27ad0e5efc8d11eb83/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Warfarin NA tablets under solicitation number VA-25-00012328. The objective of this procurement is to establish a reliable supply contract for Warfarin tablets to ensure consistent availability and pricing through the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. This initiative is crucial for maintaining a steady supply of essential pharmaceuticals, thereby supporting the government’s commitment to high-quality patient care and regulatory compliance. Interested offerors must submit their proposals by December 31, 2024, at 2:30 PM CST, and should direct any inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.

    Point(s) of Contact
    Adrienne A AlbachiaraContracting Officer
    Adrienne.Albachiara@va.gov
    Files
    Title
    Posted
    36E79725R0007_1.docx
    The Department of Veterans Affairs (VA) intends to issue Request for Proposal (RFP) 36E79725R0007 for the procurement of Warfarin Tablets, covering various specifications and quantities for distribution to multiple federal health agencies, including the Department of Defense and Bureau of Prisons. This unrestricted procurement aims to secure an uninterrupted supply for one year, with options for four additional annual periods. Offerors must provide unique labeling and a National Drug Code (NDC) linked to their product. The estimated annual usage details quantity requirements for different tablet strengths and packaging sizes, totaling various amounts across 16 product types. The solicitation is set to be electronically issued around November 13, 2024, with a response deadline of November 27, 2024. Interested vendors are encouraged to check SAM.gov for updates and to submit proposals electronically, as no paper copies will be available. Contact for inquiries is Contract Specialist Adrienne Albachiara at the provided email address.
    36E79725R0007.docx
    The document outlines a request for proposal (RFP) from the Department of Veterans Affairs (VA) for pharmaceutical supplies, specifically Warfarin NA tablets. The aim is to establish a supply contract for the VA and Department of Defense (DoD), ensuring consistent availability and pricing of medications through their Pharmaceutical Prime Vendor (PPV) Programs. To participate, offerors must provide pricing for base and option years, along with specific product documentation, including unique National Drug Codes (NDC) and color samples. Contracts will be awarded based on comprehensive compliance with the outlined requirements, including approval of manufacturing facilities by the FDA adhering to current Good Manufacturing Practices (cGMP). Additionally, details regarding the management of recalls, cost recovery fees, and quarterly sales reporting are discussed to maintain accountability in operations. This RFP represents a critical step toward securing a reliable supply chain for essential pharmaceuticals within federal health care systems, reflecting the government’s commitment to ensure excellent patient care and regulatory compliance.
    36E79725R0007 0001.docx
    The document is an amendment to Request for Proposal (RFP) 36E79725R0007, issued by the Department of Veterans Affairs for Warfarin NA Tablets. Its primary purpose is to extend the due date for offers to December 31, 2024, at 2:30 PM CST. The amendment specifies that all previous terms and conditions remain unchanged, while emphasizing the need for offerors to acknowledge receipt of the amendment to avoid rejection of their submissions. It details the administrative modifications made and indicates the proper methods for acknowledgment, including the submission of copies or electronic communication referencing the amendment. This extension allows for a more comprehensive response from potential bidders and ensures that the procurement process remains competitive and compliant with federal guidelines. Overall, the document reflects standard practices within government contracting, particularly in the healthcare sector concerning pharmaceutical procurement.
    Lifecycle
    Title
    Type
    6509--Warfarin Tablets (VA-25-00012328)
    Currently viewing
    Solicitation
    6509--Warfarin Tablets (VA-25-00012328)
    Presolicitation
    Similar Opportunities
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Abiraterone Acetate Tablets through its Pharmaceutical Prime Vendor Program. Offerors are required to comply with the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP), providing a unique 11-digit National Drug Code (NDC) for each drug, along with pricing for the base year and four optional years, including a Cost Recovery Fee. This procurement is crucial for ensuring consistent availability and competitive pricing of essential medications for federal healthcare users, particularly veterans. Interested parties must submit their proposals by the extended deadline of January 8, 2025, at 2:30 PM CST, and can contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further information.
    6505--Carbidopa/Levodopa SA Tablet
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) 36E79725R0008 for the procurement of Carbidopa/Levodopa sustained release (SA) tablets, aimed at ensuring a continuous supply of these medications for various federal health services, including the Department of Defense and the Bureau of Prisons. The contract will be awarded for an initial period of one year, with the option to extend for four additional one-year periods, requiring offerors to provide unique branding and packaging without overlapping labels. The estimated annual usage totals approximately 119,875 bottles across two dosage forms, highlighting the importance of these medications in treating Parkinson's disease and related conditions. Interested parties should note that the electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026; questions can be directed to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov.
    6505--Baclofen Tablets (VA-25-00026620)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0015 for the procurement of Baclofen Tablets, aimed at ensuring a reliable supply for various federal health facilities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The procurement will cover a one-year contract with four additional pre-priced option years, requiring offerors to provide products labeled with their unique National Drug Code (NDC) numbers. This initiative is critical for maintaining uninterrupted access to essential medications for veterans and other federal health service users. Interested suppliers should note that the solicitation will be electronically posted on or around December 30, 2024, with a submission deadline of January 13, 2025; inquiries can be directed to Contract Specialist Adrienne A. Albachiara at adrienne.albachiara@va.gov.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the procurement of Verapamil Hydrochloride (HCL) Tablets, aimed at establishing a contract for the supply of this pharmaceutical product through the VA and Department of Defense Pharmaceutical Prime Vendor Programs. The solicitation requires compliance with current Good Manufacturing Practices (cGMP) and mandates a unique National Drug Code (NDC) for each product offered, ensuring adherence to FDA regulations and drug supply chain security measures. Interested contractors must submit their proposals by December 31, 2024, at 2:30 PM CST, and can direct inquiries to Contract Specialist Nicholas I. McGregor at Nicholas.McGregor@va.gov for further information.
    6505--Metformin IR Tablets - REPACK PROGRAM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Metformin HCL IR Tablets under solicitation number 36E79725R0013. This procurement aims to ensure a consistent supply of Metformin for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center, with a contract term of one year and four optional annual extensions. The successful bidders must provide unique drug labeling with a distinct National Drug Code (NDC), as the packaging must exclusively display the contractor's label without overlapping with others. The solicitation is expected to be released electronically on January 21, 2025, with a submission deadline of February 4, 2025. Interested parties can direct inquiries to Contracting Officer Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a reliable supply of these essential pharmaceuticals for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), reflecting the government's commitment to providing necessary medications to veterans and associated healthcare systems. The contract will have an initial duration of one year, with the possibility of four additional one-year extensions, and interested vendors must provide specific drug labeling along with a unique National Drug Code (NDC). The RFP is expected to be released electronically around December 20, 2024, with a submission deadline set for January 3, 2025. For further inquiries, interested parties can contact Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.
    R614--PHARMACY/WALLTOWALLINVENTORY l CO (VA-25-00027823) 589-25-1-5622-0115
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide Annual Pharmacy Wall to Wall Inventory services for the Harry S Truman VA Medical Center. The contract, identified as 36C25525Q0099, requires the contractor to conduct a comprehensive physical inventory of medications and supplies across multiple pharmacy locations, ensuring accurate auditing and financial reporting within a 24-hour timeframe. This procurement is crucial for maintaining the integrity of pharmaceutical practices and ensuring quality care for veterans, with an estimated total award amount of $16.5 million over the contract period from February 17, 2025, to February 28, 2029. Interested parties should contact Contracting Specialist Mark S Socha at mark.socha@va.gov for further details and to discuss eligibility, including set-aside opportunities for small businesses and service-disabled veteran-owned businesses.